Provide Professional Global BD Consulting Services

About Us

ZenithPharm, founded in 2004, Beijing, China, is a wholly foreign-owned pharmaceutical consultancy who provides professional consulting services, focusing on in-licensing to China.

Keeping in close contacts with big Chinese pharmas, we made successes in licensing more than 70 projects into China.

And in cooperation with C&R Research China Inc., which is the subsidiary of C&R Research, CRO in Korea, we provide RA and Clinical Trail services for customers.

With the professional knowledge and experiences, we bring each project to the right place and at right time.

Contact Us

Add:	Room 1211, Apartment 401 Wangjingyuan, Chaoyang District, Beijing,P.R. of China
Tel:	+86-10-64398051
Fax:	+86-10-64398051
Email:	terrykim@zenithpharm.net

ZenithPharm's CEO

Business Scope

Success Case

CRO Service

CI Park, CEO of ZenithPharm, has 18 years working experience in China pharmaceutical market.

President at Beijing Hanmi Pharma
Vice President for Sales/Marketing at XIAN-JANSSEN
International Product Manager at Janssen Headquarter in Belgium
Special Project Manager for Asia-Pacific at Janssen Headquarter in Belgium
Sales Director at Janssen Korea
Senior Advisor at JVs and many local companies

Consulting Services

We provide professional services to Pharmaceutical, Biotech, Medical Device, Health & Beauty Care and Hi-Tech companies for the opportunities of licensing and distribution of products, technology transfer, R&D collaboration, strategic alliance, JV and M&A.

We have deep insight towards China pharmaceutical market.

We have global network. With Headquarter in China, we also have Zenith Pharma USA and Zenith Pharma Korea.
We keep in closely touch with most of the Chinese companies.
OUr management possesses rich experience and vast connections in pharmaceutical industry.
Our ister company can provide regulatory affairs and clinical trial services which can facilitate us to render one-stop services.

Part of recent success cases

Licensor	Drug	Therapeutic Area	Agreement	Licensee	Model
Daewon	PELUBI	Osteoarthritis	2012.11	HB	Import finished product
LCB	LCB01-0519	Antibiotic	2012.12	MD	Tech Transfer
Yuhan	YHB 1411-2	Osteoarthritis	2013.1	ML	Tech Transfer
Ahngook	Anycough	Antitussive	2013.5	HB	Import finished product
KUP	Aceclofenac CR Tab	NSAID	2013.6	JJK	Import finished product
KUP	Cilostazol SR Tab	Anti-platelet aggregation	2013.6	JJK	Import finished product
Sinil	Tulobuterol Patch	Bronchitis	2013.9	KH	Import finished product
DaeHua	Four Patches		2014.1	HB	JV company
LCB	ADC	Breast Cancer	2015.8	FS	Tech Transfer